CCR5 and neoplasm: The binding of CCL5 to CCR5 on cancerous epithelial cells induces tumor growth via several signaling pathways, including the mammalian target of rapamycin (mTOR), the pathway activation of the Janus kinase signal transducer, and the activator of transcription (JAK-STAT) pathway [9,11].